z-logo
open-access-imgOpen Access
Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
Author(s) -
He Zifan,
Li Anlin,
Lin Dagui,
Gu Yang,
Chen Yongjian,
Ou Qiyun,
Li Liren,
Yao Herui,
Yu Yunfang
Publication year - 2020
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.214
Subject(s) - medicine , oncology , proportional hazards model , hazard ratio , cancer , biomarker , exome sequencing , immune checkpoint , mutation , exome , bioinformatics , immunotherapy , cancer research , gene , biology , genetics , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom